CRI's new website that seeks to engage, educate, and empower patients and their loved ones to learn more about cancer immunotherapy as a treatment option across numerous tumor types.
Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.
By running in a marathon or hosting a bake sale, you can make a real difference for our scientists in the fight against cancer and allow them to bring newer immunotherapies to more patients.
We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.
Numerous challenges can derail progress in finding new immune-based cancer treatments. We're solving some of the biggest challenges, keeping promising new immunotherapies on the fast track to patients.
Curious about the latest developments in cancer immunotherapy research? Listen in as leading scientists discuss immune-based treatments across numerous cancer types in our free "Breakthroughs in Cancer Immunotherapy" webinar series.
When the Cancer Research Institute was founded in 1953, we knew then that immune-based treatments would transform cancer medicine. In more than six decades since, we've made numerous groundbreaking discoveries that have given more patients new hope today.
March 29, 2013
Join Team CRI in running the 2013 Marine Corps Marathon on October 27, 2013, in Arlington, VA.
A breakthrough new treatment that genetically modifies immune cells in cancer patients is showing tremendous promise in helping adults with an aggressive form of leukemia.
gene therapy, leukemia, T cell therapy
The New York Observer named Cancer Research Institute Young Philanthropists Council chair Alexis Feldman as one of its "20 Under 40" Top Young Philanthropists in its 2013 annual philanthropy supplement.
in the news, young philanthropists
Fundraising tips from a staff member turned community fundraiser/half marathon runner!
community fundraising, marathon, Team CRI
Mark Sundrud, a former CRI Irvington Postdoctoral Fellow (2006-2009) has been appointed assistant professor in the Department of Cancer Biology at The Scripps Research Institute.
Seeking out highly trained doctors at expert medical centers gives ovarian and other cancer patients two advantages—best standard of care treatment and better access to clinical trials.
clinical trials, ovarian cancer
Cancer Research Institute has launched a new website that features expert information on the latest breakthroughs in cancer immunotherapy, helpful patient information, videos, infographics, and more.
The Winter 2013 issue of The Researcher, CRI's print newsletter, is now available online.